SCHEMBL7304710

SCHEMBL7304710

CC[C@H](C)[C@H](NC(=O)OCc1ccc2ccccc2n1)C(=O)N[C@@H](Cc1ccccc1)[C@@H]1O[C@@H]1[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccc2ccccc2n1)[C@@H](C)CC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.47
CTSB P07858 2/20 0.47
CTSS P25774 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 1/20 0.46
CTSD P07339 2/20 0.45
CASP3 P42574 10/20 0.43
CASP7 P55210 6/20 0.42
CASP1 P29466 2/20 0.42
CASP9 P55211 2/20 0.42
CTSK P43235 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299914 0.92 CASP3 (0.49) CTSDCASP3CASP7CASP1CASP9
SCHEMBL7297072 0.89 CTSD (0.48) CTSLCTSBCTSSCTSDCASP3
SCHEMBL7299517 0.84 CYP3A4 (0.45) CTSDCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7299398 0.81 CTSL (0.48) CTSLCTSBCTSSMEN1KMT2A
SCHEMBL7304085 0.81 CTSL (0.48) CTSLCTSBCTSSMEN1KMT2A
SCHEMBL7295829 0.80 CYP3A4 (0.43) CTSBCTSSCTSDCASP3CASP7
SCHEMBL7308154 0.79 CYP3A4 (0.46) CTSBCTSSCTSDCASP3CASP7
SCHEMBL8657097 0.79 CTSB (0.55) CTSLCTSBCTSSMEN1KMT2A
SCHEMBL7306108 0.77 CTSD (0.55) CTSLCTSBCTSSCTSDCASP3
SCHEMBL9233070 0.77 CTSD (0.58) CTSDCASP3CASP7CASP1CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0652009-A1 Identification and use of protease inhibitors ELI LILLY AND COMPANY (US) 1995-05-10 EP disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed